| Q45930200 | Association of metabolic syndrome with smoking and alcohol intake in Japanese men. |
| Q36526890 | Association of restaurant smoking ban and the incidence of acute myocardial infarction in Finland |
| Q57654182 | Cardiovascular benefits of smoking regulations: The effect of decreased exposure to passive smoking |
| Q35077951 | Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-κB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract |
| Q45071759 | Chronic exposure to electronic cigarette (E-cig) results in impaired cardiovascular function in mice |
| Q35200735 | Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment |
| Q47556269 | Comprehensive review of cardiovascular toxicity of drugs and related agents. |
| Q37614187 | Coronary heart disease attributable to passive smoking: CHD Policy Model |
| Q28749132 | Exposure to acrolein by inhalation causes platelet activation |
| Q36330283 | Gender differences in first and secondhand smoke exposure, spirometric lung function and cardiometabolic health in the old order Amish: A novel population without female smoking |
| Q36992218 | Glutathione S-transferase polymorphisms, passive smoking, obesity, and heart rate variability in nonsmokers |
| Q40429999 | Greater Coronary Heart Disease Risk With Lower Intensity and Longer Duration Smoking Compared With Higher Intensity and Shorter Duration Smoking: Congruent Results Across Diverse Cohorts |
| Q35119332 | Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1937360 people in England: lifetime risks and implications for risk prediction. |
| Q40833421 | How acute and reversible are the cardiovascular risks of secondhand smoke? |
| Q34717413 | Impact of Scotland's comprehensive, smoke-free legislation on stroke |
| Q90160588 | Impact of second-hand smoke exposure followed by cigarette smoking quitting on subsequent risk of coronary heart disease: Evidence from the population-based cohort of Tehran Lipid and Glucose Study (TLGS) |
| Q37197102 | Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease |
| Q44557906 | Implications of a public smoking ban. |
| Q36494912 | Insula reactivity to negative stimuli is associated with daily cigarette use: A preliminary investigation using the Human Connectome Database |
| Q88595216 | Longitudinal Associations of Smoke-Free Policies and Incident Cardiovascular Disease: CARDIA Study |
| Q36033035 | Low-dose nonlinear effects of smoking on coronary heart disease risk |
| Q27310703 | Meta-analysis of the association between second-hand smoke exposure and ischaemic heart diseases, COPD and stroke |
| Q34172188 | Meta-analysis of the association between secondhand smoke exposure and stroke. |
| Q36790211 | Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein |
| Q37373701 | Oxidative stress and accelerated vascular aging: implications for cigarette smoking |
| Q37673027 | Primary prevention of cardiovascular disease: A review of contemporary guidance and literature |
| Q34700887 | Reductions in cardiovascular, cerebrovascular, and respiratory mortality following the national irish smoking ban: interrupted time-series analysis. |
| Q39012939 | Risk factors in periodontology: a conceptual framework. |
| Q33828249 | Risk of Cardiovascular Disease from Cumulative Cigarette Use and the Impact of Smoking Intensity |
| Q34460345 | Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. |
| Q57224380 | Secondhand smoke exposure and osteoporosis in never-smoking postmenopausal women: the Fourth Korea National Health and Nutrition Examination Survey |
| Q44658466 | Smoking ban in public areas is associated with a reduced incidence of hospital admissions due to ST-elevation myocardial infarctions in non-smokers. Results from the Bremen STEMI Registry |
| Q33949619 | Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial |
| Q47937098 | Smoking, plasma cotinine and risk of atrial fibrillation: the Hordaland Health Study |
| Q33299389 | Smoking-attributable morbidity: acute care hospital diagnoses and days of treatment in Canada, 2002 |
| Q50150358 | Substance-attributable morbidity and mortality changes to Canada's epidemiological profile: measurable differences over a ten-year period. |
| Q34326163 | The biology behind the atherothrombotic effects of cigarette smoke |
| Q36812204 | The impact of a smoking ban on hospital admissions for coronary heart disease |
| Q37738339 | The role of smoking cessation in the prevention of coronary artery disease |
| Q47335397 | Tobacco Smoke Exposure Association With Lipid Profiles and Adiposity Among U.S. Adolescents |
| Q57571736 | Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study |
| Q53233329 | Trends in body mass index, blood pressure and parental smoking habits in middle socio-economic level Turkish adolescents. |
| Q36117440 | Use of E-Cigarettes Among Current Smokers: Associations Among Reasons for Use, Quit Intentions, and Current Tobacco Use. |
| Q84025830 | [Why must we support the laws on smoke free zones?] |